Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OraSoothe is a line of topical oral care products, including rinses and gels (such as Sockit Gel), developed by Cook-Waite (a Septodont brand) for the management of oral pain and mucosal soothing. These products are FDA-cleared oral hydrogel wound dressings composed of natural, food-based ingredients, including mannose polysaccharides from Aloe vera, xylitol, and essential oils (cinnamon, clove, thyme, and wintergreen). OraSoothe works through a dual mechanism: it forms a protective physical barrier over injured oral tissues and binds positively charged sodium ions to inhibit the transmission of pain signals. Unlike traditional topical anesthetics, it provides pain relief without numbing. It is indicated for use after invasive dental procedures like extractions, implants, and periodontal surgeries, as well as for conditions like oral mucositis and aphthous ulcers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OraSoothe.